E-DRUG: webinar Jan 15 - Using competition law to address high medicines prices
------------------------------------------------------------------------------------------------
Dear members of the essential drugs list,
We are pleased to invite you to the next webinar organised by the Knowledge
Network on Innovation and Access to Medicines, presenting recent research
on topics relating to pharmaceuticals policy, which we believe is of
interest to this list.
*Using competition law to address high medicines prices*
Tuesday 15 January | 4:00pm-5:00pm CET
Speaker:
Frederick Abbott <http://frederickabbott.com/> is Professor of
International Law at Florida State University College of Law.
Paper:
Excessive Pharmaceutical Prices and Competition Law: Doctrinal Development
to Protect Public Health <https://www.ssrn.com/abstract=2719095>
Background
One of the main objectives of competition law is to protect consumers
against abusive practices. However, it has rarely been used to directly
address excessive prices for medicines. Debates around the opportunities
and challenges of using competition law to address the problem of high
prices of medicines are increasing worldwide. Some of the main questions
include: Can competition law be used in case of a lawful monopoly, such as
those acquired through patents or regulatory measures? When is a price high
enough to qualify as 'excessive'?
Prof. Frederick Abbott will address these questions and present his
research on the doctrine of excessive pricing applied to the pharmaceutical
sector, based on his 2016 article and a number of significant subsequent
developments. He will present the main arguments for using competition law
to address high medicines prices and technical aspects of how to determine
when prices are excessive (e.g. considering cost of production, cost of
development, degrees of risk).
Who should consider attending?
Those interested in learning more about:
- Excessive pricing of medicines and cost of production and development
- Competition law as a tool to address high prices of pharmaceutical
products
What should you expect to hear?
- An overview on the use of competition law and the doctrine of excessive
pricing applied to the pharmaceutical sector
- How to determine excessive pricing of pharmaceutical products
To join the webinar on Tuesday 15 January, please register here
<https://zoom.us/webinar/register/4915469553113/WN_JwGq9dBsTSG-MQIp4WJuuA>\.
Participants will be able to pose questions orally and in writing during
the webinar, and the speaker will respond to a selection of these during
the second half of the event. Recordings of all webinars will be made
available online after they take place at the Global Health Centre webpage
After registering, you will receive a confirmation email with additional
information on how to join the webinar.
We hope you will be able to join us for this informative presentation. This
event is part of the webinar series of the Knowledge Network for Innovation
and Access to Medicines, a project of the Global Health Centre at the
Graduate Institute of Geneva.
Suggestions for speakers and topics for
future webinars are welcome at
globalhealthresearch@graduateinstitute.ch.
Marcela Vieira
Project Coordinator
Knowledge Network for Innovation and Access to Medicines
Global Health Centre, Research
marcela.vieira@graduateinstitute.ch